BenchSci, a leading provider of AI software for biopharma research and development, today announced the appointment of Dr. Mikael Dolsten, M.D., Ph.D., as Chairman of its Board of Directors, effective ...
At least two workers filed lawsuits alleging “dangerous” conditions at the former Pfizer building before it partially caved ...
Slamming the developers of the E. 42nd St. residential conversion project as reckless, a construction union says the site’s ...
MetroLoft founder Nathan Berman calls the Manhattan high-rise structural damage a "freak accident" limited to a 20-by-20-foot ...
In the open-label study, DMD patients received Satellos’ oral drug for an additional 11 months, following an earlier 28-day trial.
The streets around a midtown Manhattan high-rise where buckled columns forced evacuations gradually returned to life ...
ATTR-CM treatment options narrowed after AstraZeneca and Ionis revealed their gene-silencing drug Wainua (eplontersen) failed ...
A building almost collapsed in Manhattan. The backstory is surprisingly hopeful.
As officials continue to investigate the cause, experts say that if the conversion is to proceed, "extensive work" would need ...
Astellas Pharma US, Inc. (Head of US Commercial: Michael Petroutsas, "Astellas") today announced new research insights at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results